Epstein–Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients

Abstract

The prognostic value of the Epstein–Barr virus (EBV) DNA load in sera of nasopharyngeal carcinoma (NPC) patients measured before any treatment, after treatment and before relapse was assessed. The real-time polymerase chain reaction was used to detect the viral load levels among 74 NPC subjects. Patients were followed up for a period going from 1 to 6 years (median 4 years). Before treatment, the EBV DNA load was correlated with lymph node involvement and advanced stages. After treatment, the viral load level declined significantly and patients presenting a viral load level lower than 1000 copies/ml showed a better overall survival (OS). Moreover, a significant result was found when the 6-year OS rates of patients having fewer or more than 15,000 copies/ml of viral load before relapse were compared. These results suggest that the EBV DNA load quantification after treatment may be a useful predictor of disease progression and survival.

Keywords::

• EBV DNA load
• NPC
• prognosis
• survivals

Acknowledgements

We thank Mr. Adel Rdissi for English revision.

Declaration of interest

This work was supported by le Ministère de l’Enseignement Supérieur, de la recherche scientifique et de la technologie and by le Ministère de la Santé Publique de la République Tunisienne.